Market Tracker

05/05 9:08am ET

Nektar Therapeutics (NASDAQ:NKTR)

14.02
Delayed Data
As of May 04
 -1.57 / -10.07%
Today’s Change
9.16
Today|||52-Week Range
17.55
-16.80%
Year-to-Date

Today’s Trading

Previous close15.59
Today’s open15.21
Day’s range13.60 - 15.36
Volume2,943,297
Average volume (3 months)1,602,091
Market cap$2.1B
Dividend yield--
Data as of 05/04/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-62.06%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book328.07

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...-1.16-2.64%
DBVTDBV Technologies SA-1.51-4.52%
PRAHPRA Health Sciences ...-0.52-1.16%
LXRXLexicon Pharmaceutic...-1.00-7.65%
Data as of 05/04/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts